Deutsche Bank Aktiengesellschaft Has Lowered Expectations for CME Group (NASDAQ:CME) Stock Price

Key Points

• Deutsche Bank cut its price target on CME to $322 (from $342) but kept a "buy" rating; other firms also trimmed targets, leaving a consensus average target of $306.71 and an overall analyst view of "Moderate Buy."
• CME beat Q1 expectations with $3.36 EPS (vs. $3.11 est.) and record revenue and trading volumes, yet the stock traded near $281.58 and some analysts warn forward valuation may limit further upside.
• Company insiders sold about 8,539 shares (~$2.7M) over the last three months while institutional ownership remains high at roughly 87.75%.

CME Group (NASDAQ:CME - Get Free Report) had its target price dropped by equities researchers at Deutsche Bank Aktiengesellschaft from $342.00 to $322.00 in a research report issued to clients and investors on Thursday,MarketScreener reports. The firm presently has a "buy" rating on the financial services provider's stock. Deutsche Bank Aktiengesellschaft's price objective suggests a potential upside of 14.36% from the stock's previous close.

A number of other equities analysts have also weighed in on the company. Barclays dropped their price objective on CME Group from $343.00 to $316.00 and set an "equal weight" rating for the company in a research note on Thursday. The Goldman Sachs Group dropped their price objective on CME Group from $275.00 to $267.00 and set a "sell" rating for the company in a research note on Thursday. Morgan Stanley dropped their price objective on CME Group from $362.00 to $353.00 and set an "overweight" rating for the company in a research note on Thursday. Royal Bank Of Canada upped their price objective on CME Group from $295.00 to $302.00 and gave the stock a "sector perform" rating in a research note on Thursday, February 5th. Finally, TD Cowen dropped their price objective on CME Group from $340.00 to $323.00 and set a "buy" rating for the company in a research note on Thursday. Two research analysts have rated the stock with a Strong Buy rating, eight have issued a Buy rating, six have given a Hold rating and two have given a Sell rating to the company's stock. According to MarketBeat.com, CME Group has an average rating of "Moderate Buy" and an average target price of $306.71.

CME Group Price Performance

Shares of NASDAQ CME traded down $3.89 during mid-day trading on Thursday, reaching $281.58. The company's stock had a trading volume of 94,120 shares, compared to its average volume of 2,289,486. The firm has a market capitalization of $100.98 billion, a PE ratio of 24.02, a P/E/G ratio of 2.91 and a beta of 0.26. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.03. The stock has a fifty day moving average of $304.87 and a two-hundred day moving average of $285.91. CME Group has a 52 week low of $257.17 and a 52 week high of $329.16.

CME Group (NASDAQ:CME - Get Free Report) last released its quarterly earnings data on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share for the quarter, topping analysts' consensus estimates of $3.11 by $0.25. The firm had revenue of $1.88 billion during the quarter, compared to analyst estimates of $1.77 billion. CME Group had a return on equity of 15.42% and a net margin of 63.19%.The business's quarterly revenue was up 14.5% compared to the same quarter last year. During the same quarter in the prior year, the company posted $2.80 earnings per share. As a group, sell-side analysts anticipate that CME Group will post 12.37 EPS for the current fiscal year.

Insider Buying and Selling

In other CME Group news, General Counsel Jonathan L. Marcus sold 3,291 shares of the company's stock in a transaction that occurred on Tuesday, March 17th. The stock was sold at an average price of $333.37, for a total transaction of $1,097,120.67. Following the sale, the general counsel directly owned 7,192 shares in the company, valued at $2,397,597.04. This represents a 31.39% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, Director Bryan T. Durkin sold 4,200 shares of the company's stock in a transaction that occurred on Monday, February 23rd. The shares were sold at an average price of $309.65, for a total value of $1,300,530.00. Following the sale, the director owned 43,007 shares in the company, valued at approximately $13,317,117.55. This trade represents a 8.90% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 8,539 shares of company stock valued at $2,713,821. 0.30% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On CME Group

Hedge funds and other institutional investors have recently modified their holdings of the business. Caldwell Trust Co raised its holdings in shares of CME Group by 116.3% in the third quarter. Caldwell Trust Co now owns 93 shares of the financial services provider's stock worth $25,000 after buying an additional 50 shares during the period. Asset Dedication LLC raised its holdings in shares of CME Group by 64.9% in the fourth quarter. Asset Dedication LLC now owns 94 shares of the financial services provider's stock worth $26,000 after buying an additional 37 shares during the period. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA purchased a new stake in shares of CME Group in the third quarter worth approximately $27,000. FNY Investment Advisers LLC purchased a new stake in shares of CME Group in the fourth quarter worth approximately $27,000. Finally, Elkhorn Partners Limited Partnership purchased a new stake in shares of CME Group in the fourth quarter worth approximately $27,000. 87.75% of the stock is currently owned by hedge funds and other institutional investors.

Trending Headlines about CME Group

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: Record Q1 revenue and surge in trading volumes: CME reported record Q1 revenue and a big rise in average daily volume, driven by increased hedging and risk-taking activity—this is the primary driver for the stock's upside today. Article Title
• Positive Sentiment: Morgan Stanley trims target but stays Overweight: Morgan Stanley cut its PT to $353 from $362 but kept an Overweight rating, signaling continued analyst confidence and upside (~23.7% from the referenced price). Article Title
• Positive Sentiment: TD Cowen lowers target but maintains Buy: TD Cowen trimmed its PT to $323 (from $340) but kept a Buy rating, indicating analysts still see material upside despite more conservative forecasts. Article Title
• Neutral Sentiment: Earnings-call detail and full transcripts available: Management’s call and full transcripts provide color on product mix, client behavior, and seasonality—useful for modeling but not new headline catalysts. Article Title
• Negative Sentiment: Some outlets say Q1 sales/metrics missed estimates: Several reports note revenue or sales came in below analyst expectations on a few metrics despite strong volumes—this fuels profit-taking and keeps upside capped. Article Title
• Negative Sentiment: Goldman cuts target to $267 and retains Sell: Goldman Sachs lowered its PT and continues to carry a Sell rating, which adds downward pressure and contributes to mixed analyst chatter. Article Title
• Negative Sentiment: Some analysts warn valuation remains high: Commentary (e.g., Seeking Alpha) points out the stock still looks expensive on forward multiples despite strong top-line momentum—this may limit sustained upside. Article Title

About CME Group

CME Group Inc is a global markets company that operates some of the world's largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company's core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.